Under HFD, the Dnmt3a+/–-CH group progressed to severe MASLD, with marked hepatitis reflected by high nonalcoholic fatty liver disease activity score (3) and extensive fibrosis (Figure 1, L–N). This evidence concerns the gene DNMT3A and metabolic dysfunction-associated steatotic liver disease.